• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金(I)膦介导的淋巴酪氨酸磷酸酶的选择性抑制。

Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.

机构信息

University of Utah Department of Medicinal Chemistry, Salt Lake City, UT 84112, United States.

出版信息

J Inorg Biochem. 2010 Mar;104(3):268-73. doi: 10.1016/j.jinorgbio.2009.12.012. Epub 2009 Dec 28.

DOI:10.1016/j.jinorgbio.2009.12.012
PMID:20083307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2873867/
Abstract

Selective protein tyrosine phosphatase (PTP) inhibition is often difficult to achieve owing to the high degree of similarity of the catalytic domains of this family of enzymes. Selective inhibitors of the lymphoid specific tyrosine phosphatase, LYP, are of great interest due to the involvement of LYP in several autoimmune disorders. This manuscript describes a study into the mechanistic details of selective LYP inhibition by a Au(I)-phosphine complex. The complex, [Au((CH(2)CH(2)CN)(2)PPh)Cl], selectively inhibits LYP activity both in vitro and in cells, but does not inhibit other T-cell derived PTPs including the highly homologous PTP-PEST. The mode of inhibition was probed by investigating inhibition of LYP, the LYP mutant C129/231S, and PTP-PEST. Inhibition of LYP and PTP-PEST was competitive, while the LYP double mutant appeared mixed. Wild-type LYP was inhibited more potently than LYP C129/231S, indicating an important role for at least one of these residues in Au(I) binding. Coordination of Au(I) by both the active site cysteine residue as well as either Cys129 or 231 is suggested as a potential mechanism for LYP selective inhibition.

摘要

由于该酶家族的催化结构域具有高度相似性,因此选择性蛋白酪氨酸磷酸酶(PTP)抑制通常难以实现。由于淋巴特异性酪氨酸磷酸酶 LYP 参与了多种自身免疫性疾病,因此对 LYP 的选择性抑制剂的研究具有重要意义。本文描述了一种通过 Au(I)-膦配合物对选择性 LYP 抑制的机制细节研究。该配合物 [Au((CH(2)CH(2)CN)(2)PPh)Cl],在体外和细胞内均能选择性地抑制 LYP 活性,但不能抑制其他 T 细胞衍生的 PTP,包括高度同源的 PTP-PEST。通过研究 LYP、LYP 突变体 C129/231S 和 PTP-PEST 的抑制作用,探测了抑制作用的模式。对 LYP 和 PTP-PEST 的抑制是竞争性的,而 LYP 双突变体则表现出混合性。野生型 LYP 的抑制作用比 LYP C129/231S 更强,这表明至少有一个残基在 Au(I)结合中起重要作用。Au(I)与活性位点半胱氨酸残基以及 Cys129 或 231 的配位被认为是 LYP 选择性抑制的潜在机制。

相似文献

1
Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.金(I)膦介导的淋巴酪氨酸磷酸酶的选择性抑制。
J Inorg Biochem. 2010 Mar;104(3):268-73. doi: 10.1016/j.jinorgbio.2009.12.012. Epub 2009 Dec 28.
2
Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity.淋巴特异性蛋白酪氨酸磷酸酶(Lyp)活性的靶向特异性控制。
Bioorg Med Chem. 2010 Jul 15;18(14):4884-91. doi: 10.1016/j.bmc.2010.06.022. Epub 2010 Jun 12.
3
Identifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au(I) complexes.从一系列金(I)配合物中鉴定出强效、选择性的蛋白酪氨酸磷酸酶抑制剂。
J Med Chem. 2009 Nov 12;52(21):6912-8. doi: 10.1021/jm901220m.
4
Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.鉴定和结构功能分析一种酪氨酸磷酸酶 PTPN22 的别构抑制剂。
J Biol Chem. 2019 May 24;294(21):8653-8663. doi: 10.1074/jbc.RA118.007129. Epub 2019 Apr 12.
5
Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.Lyp(一种与自身免疫性疾病相关的淋巴细胞特异性酪氨酸磷酸酶)的结构、抑制剂及调节机制
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19767-72. doi: 10.1073/pnas.0706233104. Epub 2007 Dec 3.
6
Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.淋巴特异性酪氨酸磷酸酶(Lyp):治疗自身免疫性疾病的潜在药物靶点。
Curr Drug Targets. 2014 Mar;15(3):335-46. doi: 10.2174/13894501113146660236.
7
Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.硫代双胍类作为淋巴酪氨酸磷酸酶的拟不可逆抑制剂。
ChemMedChem. 2013 Sep;8(9):1561-8. doi: 10.1002/cmdc.201300215. Epub 2013 Jul 19.
8
Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain.淋巴样酪氨酸磷酸酶活性的调节:近端结构域间区域对催化结构域的抑制作用。
Biochemistry. 2009 Aug 11;48(31):7525-32. doi: 10.1021/bi900332f.
9
Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotype.人类淋巴酪氨酸磷酸酶催化结构域的不同功能和构象状态可以通过选择抑制剂化学型来靶向。
J Comput Aided Mol Des. 2011 Sep;25(9):873-83. doi: 10.1007/s10822-011-9469-2. Epub 2011 Sep 9.
10
Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W.淋巴特异性酪氨酸磷酸酶(Lyp)变体 S201F 和 R266W 的生化和功能研究。
PLoS One. 2012;7(8):e43631. doi: 10.1371/journal.pone.0043631. Epub 2012 Aug 27.

引用本文的文献

1
Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy.具有增强的同工酶选择性和细胞功效的PTPN22抑制剂的构效关系研究与设计
Eur J Med Chem. 2025 Feb 5;283:117129. doi: 10.1016/j.ejmech.2024.117129. Epub 2024 Dec 6.
2
Multipartite Fluorogenic Sensors for Monitoring Tyrosine Phosphatase Activity.用于监测酪氨酸磷酸酶活性的多组分荧光传感器
Chembiochem. 2024 Dec 16;25(24):e202400607. doi: 10.1002/cbic.202400607. Epub 2024 Nov 14.
3
Interrogating Protein Phosphatases with Chemical Activity Probes.用具有化学活性的探针来探究蛋白磷酸酶。
Chemistry. 2018 Jun 4;24(31):7810-7824. doi: 10.1002/chem.201705194. Epub 2018 Mar 8.
4
Covalent inhibition of protein tyrosine phosphatases.蛋白质酪氨酸磷酸酶的共价抑制作用。
Mol Biosyst. 2017 Jun 27;13(7):1257-1279. doi: 10.1039/c7mb00151g.
5
Inhibition of the lymphoid tyrosine phosphatase: the effect of zinc(II) ions and chelating ligand fragments on enzymatic activity.淋巴样酪氨酸磷酸酶的抑制作用:锌(II)离子和螯合配体片段对酶活性的影响。
Bioorg Med Chem Lett. 2014 Aug 15;24(16):4019-22. doi: 10.1016/j.bmcl.2014.06.016. Epub 2014 Jun 16.
6
Covalent inhibition of the lymphoid tyrosine phosphatase.淋巴样酪氨酸磷酸酶的共价抑制作用。
ChemMedChem. 2014 Feb;9(2):296-9. doi: 10.1002/cmdc.201300404. Epub 2014 Jan 8.
7
Substrate selection influences molecular recognition in a screen for lymphoid tyrosine phosphatase inhibitors.筛选淋巴酪氨酸磷酸酶抑制剂的实验中,底物选择会影响分子识别。
Chembiochem. 2013 Sep 2;14(13):1640-7. doi: 10.1002/cbic.201300273. Epub 2013 Aug 16.
8
Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.硫代双胍类作为淋巴酪氨酸磷酸酶的拟不可逆抑制剂。
ChemMedChem. 2013 Sep;8(9):1561-8. doi: 10.1002/cmdc.201300215. Epub 2013 Jul 19.
9
A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases.一种针对淋巴特异性酪氨酸磷酸酶(LYP)的有效且选择性的小分子抑制剂,LYP 是一种与自身免疫性疾病相关的靶点。
J Med Chem. 2013 Jun 27;56(12):4990-5008. doi: 10.1021/jm400248c. Epub 2013 Jun 6.

本文引用的文献

1
Identifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au(I) complexes.从一系列金(I)配合物中鉴定出强效、选择性的蛋白酪氨酸磷酸酶抑制剂。
J Med Chem. 2009 Nov 12;52(21):6912-8. doi: 10.1021/jm901220m.
2
Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation .人类淋巴样酪氨酸磷酸酶催化结构域的晶体结构:对氧化还原调节的见解
Biochemistry. 2009 Jun 9;48(22):4838-45. doi: 10.1021/bi900166y.
3
A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus.蛋白酪氨酸磷酸酶非受体型22(PTPN22)的功能丧失变异与系统性红斑狼疮风险降低相关。
Hum Mol Genet. 2009 Feb 1;18(3):569-79. doi: 10.1093/hmg/ddn363. Epub 2008 Nov 3.
4
Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study.金(I)介导的蛋白酪氨酸磷酸酶抑制作用:一项详细的体外和细胞研究。
J Med Chem. 2008 Aug 14;51(15):4790-5. doi: 10.1021/jm800101w. Epub 2008 Jul 8.
5
Protein tyrosine phosphatases in autoimmunity.自身免疫中的蛋白酪氨酸磷酸酶
Annu Rev Immunol. 2008;26:29-55. doi: 10.1146/annurev.immunol.26.021607.090418.
6
Essential function of PTP-PEST during mouse embryonic vascularization, mesenchyme formation, neurogenesis and early liver development.蛋白酪氨酸磷酸酶PEST在小鼠胚胎血管形成、间充质形成、神经发生和早期肝脏发育过程中的重要功能。
Mech Dev. 2006 Dec;123(12):869-80. doi: 10.1016/j.mod.2006.08.011. Epub 2006 Sep 1.
7
Inhibition of lysosomal cysteine proteases by a series of Au(I) complexes: a detailed mechanistic investigation.一系列金(I)配合物对溶酶体半胱氨酸蛋白酶的抑制作用:详细的机理研究。
J Med Chem. 2006 Jun 29;49(13):3933-7. doi: 10.1021/jm060158f.
8
Role of PTPN22 in type 1 diabetes and other autoimmune diseases.蛋白酪氨酸磷酸酶非受体型22(PTPN22)在1型糖尿病及其他自身免疫性疾病中的作用
Semin Immunol. 2006 Aug;18(4):207-13. doi: 10.1016/j.smim.2006.03.008. Epub 2006 May 11.
9
Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.膦金(I)配合物作为人类二硫键还原酶的不可逆抑制剂的去配位作用
Angew Chem Int Ed Engl. 2006 Mar 13;45(12):1881-6. doi: 10.1002/anie.200502756.
10
Identification of substrates of human protein-tyrosine phosphatase PTPN22.人蛋白酪氨酸磷酸酶PTPN22底物的鉴定
J Biol Chem. 2006 Apr 21;281(16):11002-10. doi: 10.1074/jbc.M600498200. Epub 2006 Feb 6.